HC Wainwright reiterated their buy rating on shares of Sutro Biopharma (NASDAQ:STRO – Free Report) in a research note released on Tuesday, Benzinga reports. They currently have a $12.00 target price on the stock. HC Wainwright also issued estimates for Sutro Biopharma’s Q2 2024 earnings at ($0.99) EPS, Q3 2024 earnings at ($1.01) EPS, Q4 […]
Oppenheimer Reaffirms Outperform Rating for Sutro Biopharma (NASDAQ:STRO) dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
Oppenheimer restated their outperform rating on shares of Sutro Biopharma (NASDAQ:STRO – Free Report) in a research note issued to investors on Wednesday morning, Benzinga reports. The brokerage currently has a $10.00 target price on the stock. STRO has been the topic of a number of other reports. Piper Sandler reaffirmed an overweight rating and […]
Oppenheimer reissued their outperform rating on shares of Sutro Biopharma (NASDAQ:STRO – Free Report) in a research note issued to investors on Wednesday, Benzinga reports. Oppenheimer currently has a $10.00 target price on the stock. STRO has been the topic of a number of other research reports. Truist Financial lowered their price target on Sutro […]
Sutro Biopharma (NASDAQ:STRO) Rating Reiterated by HC Wainwright theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.